“Life without disease” is the rallying call for Oncotarget. Oncotarget is a multidisciplinary journal with free access. The word “oncotarget” was coined to mean all processes and substances that pertain to cancer and aging of cells. It began as a journal for Oncology. It bore huge success due to its accommodative and punctual nature. This prompted its expansion to encompass other disciplines such as Microbiology and Immunology.
Oncotarget allows people to present their research papers. It gives a second chance to people whose articles have been rejected by other journals. It allows for constructive peer reviews. This allows one’s research to have the most impact. Publishing of papers is timely and is done on a weekly basis. It further allows meshing up of biomedical fields leading to integrative medicine. Oncotarget, which is published by Impact Journals
It also allows new findings to be published with haste.This journal is run by a team of top-notch scientists. They do this in various capacities of Editors-in Chief and members of the Editorial Board. These authors are tried and tested. Individual members of Oncotarget have won various accolades since 2013. These include the coveted Nobel Peace Prize and the Breakthrough Prize.
You can then be sure that you are submitting your work to an able panel of medical pundits.In the spirit of quicker publishing of papers, Oncotarget sponsors the Gordon Research conference. This is an annual conference aimed at showcasing new scientific findings. It also gives the opportunities to younger researchers to present papers, network with seasoned researchers and to get involved in the Frontiers of Science.
Overall, Oncotarget is a committed journal aimed at maximising the impact of research work by constructive and insightful peer reviews.prompted its expansion to encompass other disciplines such as Microbiology and Immunology. Download output styles at Endnote.com